Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Myelodysplastic Syndromes (MDS)
Total 0 results
Nothing found
Sponsors and Collaborators
Donald B. Kohn, M.D.
Nelson Mandela Academic Hospital
Pompeyo Stalin Alarcón Vigil
Sociedad Panameña de Hematología
Steven B. Kleiboeker
Shenzhen Core Medical Technology CO.,LTD.
Worabe Comprehensive Specialiazed Hospital
Dr. Jochen Brack
Universidad Mayor de San Simón (UMSS, Bolivia)
Roongroj Bhidayasiri
Saw Swee Hock School of Public Health
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation
Didem OZKAL EMINOGLU
Shaoxing Mashan Street Community Health Service Center
Hospital Governador Celso Ramos
Maria de las Mercedes Perez Rodriguez
Sub-Investigator: Łucja Bieleninik, PhD
Centre Hospitalier du Quebec
MYOR Ltd.
View Full List
Medical Conditions
Bladder Cancer Recurrent
Memory Disorders
Macrocephaly Autism Syndrome
Granulomatous Disease, Chronic
Small Intestine Cancer
Malignant Tumor of Urinary System (Disorder)
Root Abscess
Parental
Bladder Recurrence
Pharmacokinetics of Ipragliflozin
Humerus Fracture Displaced Proximal
Poor Medication Adherence
Control Nausea and Vomiting
0.5-14 Year Old Children With Nephroblastoma
Urinary Bladder Neurogenic Dysfunction
Atherosclerosis Coronary Artery With Angina Pectoris
Endoscopic Surveillance
Anticoagulant Prophylaxis/Therapy
Neuroectodermal Tumor
Inoperable Stage III Non-small Cell Lung Cancer
View Full List
Drug Interventions
Campath 1H
Idelalisib
Vehicle
The drug "Rutan 0.1".
Sparsentan
FTD regimen
Bupropion Extended Release Oral Tablet
Clozapine 100 mg
Salvinorin A
Varenicline Controlled Release 1.2 mg
Ceralasertib
Letrozole
Cyclosporine A
Everolimus
Elafibranor 80mg
APG2575 800 mg
Biphasic insulin aspart 30
SAR408701 (Tusamitamab ravtansine)
Fibrin Sealant
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
View Full List
CROs by country
Contract Research Organizations in Bahamas
Contract Research Organizations in Belgium
Contract Research Organizations in Bulgaria
Contract Research Organizations in Czech Republic
Contract Research Organizations in Ethiopia
Contract Research Organizations in Lithuania
Contract Research Organizations in Mongolia
Contract Research Organizations in Nigeria
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Serbia
Contract Research Organizations in Slovakia
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Zambia
CRO list by country
CROs in Türkiye
Atlant Clinical
Celero
SGS
Fidelis Research
Monitor Medical Research and Consulting
ICON
ROSENBAUM GROUP
ZEINCRO
Omega CRO
Lonza
All CROs in Türkiye
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe